| The Continuity Study (NCT07216573) | Becton, Dickinson and Company | 2026-05-07 |
| UK PureWick™ At-Home Pilot Study (NCT07555548) | Becton, Dickinson and Company | 2026-05-06 |
| BD SiteRite(TM) 9 Ultrasound System - Clinical Study (NCT06632509) | Becton, Dickinson and Company | 2025-11-12 |
| ClearSight NextGen1 Study (NCT07317648) | Becton, Dickinson and Company | 2025-10-16 |
| HemoSphere Alta Study (NCT07148323) | Becton, Dickinson and Company | 2025-10-14 |
| BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study (NCT06632496) | Becton, Dickinson and Company | 2025-03-28 |
| Investigational Study With the BD PosiFlush™ SafeScrub on NADs (NCT06604026) | Becton, Dickinson and Company | 2024-10-22 |
| Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product (NCT06426121) | Becton, Dickinson and Company | 2024-06-26 |
| Personal BP - CAI Study (NCT06492746) | Becton, Dickinson and Company | 2024-06-03 |
| Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. (NCT05953363) | Becton, Dickinson and Company | 2023-07-24 |
| SMART TRENDS Study (NCT05957406) | Becton, Dickinson and Company | 2023-07-11 |
| Study of BD Pre-filled Flush Syringes in China (NCT05763147) | Becton, Dickinson and Company | 2022-11-03 |
| BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System. (NCT05557422) | Becton, Dickinson and Company | 2022-10-12 |
| Investigational On-body Injector Clinical Study (NCT05553418) | Becton, Dickinson and Company | 2022-09-05 |
| BD Veritor™ At-Home and BD Veritor™ Professional (NCT05352581) | Becton, Dickinson and Company | 2022-07-21 |
| BD MiniDraw™ Capillary System Clinical Equivalence Study (NCT05186311) | Becton, Dickinson and Company | 2022-04-22 |
| Prospective Clinical Evaluation of BD Spinal Needles (NCT05214560) | Becton, Dickinson and Company | 2022-02-14 |
| A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors (NCT05130762) | Becton, Dickinson and Company | 2022-01-31 |
| Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer (NCT05035615) | Becton, Dickinson and Company | 2021-11-02 |
| A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices (NCT04845906) | Becton, Dickinson and Company | 2021-07-13 |
| Prospective Healthy Volunteer Study of the Securis™ Stabilization Device (NCT04841330) | Becton, Dickinson and Company | 2021-06-09 |
| Capturing Infectious COVID-19 Asymptomatic Cases in Singapore (NCT04812327) | Becton, Dickinson and Company | 2021-06-01 |
| Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer (NCT05032339) | Becton, Dickinson and Company | 2021-05-04 |
| Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer (NCT05032313) | Becton, Dickinson and Company | 2021-04-26 |
| A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter in the Chinese Population (NCT04719377) | Becton, Dickinson and Company | 2021-01-13 |
| Impact of PIVC Length and Gauge on Catheter Indwell Time (NCT04344314) | Becton, Dickinson and Company | 2020-08-31 |
| Prospective Observational Study of the Power PICC Family of Devices and Accessories (NCT04263649) | Becton, Dickinson and Company | 2020-06-18 |
| The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus (NCT04120974) | Becton, Dickinson and Company | 2019-10-01 |
| Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes (NCT04090242) | Becton, Dickinson and Company | 2019-09-06 |
| Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles (NCT03878758) | Becton, Dickinson and Company | 2019-02-07 |
| An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform (NCT04007003) | Becton, Dickinson and Company | 2018-06-26 |
| Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle (NCT03267264) | Becton, Dickinson and Company | 2017-09-01 |
| The PSIQS Study - User Experience With Pro-Set (NCT03242005) | Becton, Dickinson and Company | 2017-09-01 |